Weekly round-up #195

VALIDATE Seminar - Vaccine Development and Sero-diagnosis of Leprosy

On 30 November 2021, Dr Yumi Maeda from the Leprosy Research Center National at the Tokyo Institute of Infectious Diseases, spoke to VALIDATE members and other researchers from around the world in VALIDATE's fInal seminar of 2021. Dr Maeda discussed and how her team has constructed a recombinant BCG that secretes Major Membrane Protein-II of M. leprae, and found that it was effective in inhibiting the growth of M. leprae in mice footpads.

VALIDATE members can watch the seminar when we upload the video on the Hub next week.

Funding:

MDPI Vaccines 2022 TraveI Awards - Financial support to attend an international conference in the field of vaccine research to be held in 2022 in order to hold a presentation, present a poster, or both – deadline 31 December 2021
Global Learning Scholarship Program - opportunities for scientists and researchers from low- and middle-income countries to access the latest ideas, science, technology and partnerships to make a positive impact on fighting global disease - various deadlines throughout 2022
MRC Experimental Medicine Funding Call - address gaps in our understanding of the causes, progression and treatment of human disease through experimental intervention, or challenge, in humans – deadline 19 January 2022

You can find a list of all relevant external funding we've spotted for our members on our external funding page.

Training Opportunities and Events:

TRANSVAC2 - Vaccine Training Courses: M3, M5, M14, training application by December 15th, 2021.

Find more training and events opportunities on our Training and Events pages.

Job Opportunities:

Postdoctoral Scientist in T cell Immunology of Vaccines, University of Oxford, deadline 6 December 2021
Assistant Professor, Harvard Medical School, MA USA, deadline 15 December 2021
Laboratory Research Scientist, Francis Crick Institute, UK, 17 January 2022

There are many more relevant career opportunities on our jobs page.

Publications:

Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection, Muflihah H et al, in Plos One
Human leishmaniasis vaccines: Use cases, target population and potential global demand, Malvolti S, Malhame M, et al, in PLoS Neglected Tropical Diseases
Vaccines against leishmaniasis: using controlled human infection models to accelerate development, Parkash V, in Expert Review of Vaccines
Leprosy: what is new, Randhawa A, Kapila R, Schwartz RA, in International Journal of Dermatology
Role of Burkholderia pseudomallei-Specific IgG2 in Adults with Acute Melioidosis, Thailand, VALIDATE member Panjaporn Chaichana et al, in Journal of.Emerging Infectious Diseases.
Biofilms in tuberculosis: What have we learnt in the past decade and what is still unexplored?, Bacon J et al, in Tuberculosis

Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.

Highlights on Twitter this week:

We had some more Twitter activity surrounding our BCG Adventures Games: Science writer Fleur Templeton shared the games and we released the latest trailer. We also launched Little Lille on Steam with numerous Twitter accounts sharing the news including the Jenner Vaccine Trials, The Dollar Game Store (the game’s developer), SteamReleases, Steam Micro Trailers, and celebrated the game trending on the Steam Website. WriteThatPhD had some more advice for writing a research proposal and how to do systematic reviews. Nature Careers discussed how burnout and imposter syndrome blight science careers and shared their collection of articles from and about women in science. Stay up to date with all the relevant news and opportunities by following @NetworkVALIDATE on Twitter.

Published: 1 December 2021